Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by YOUHEI IMAMURA
Predictive Factors in Patients With EGFR Mutation‑negative Non‑small Cell Lung Cancer Treated With Erlotinib
Oncology Letters
Cancer Research
Oncology
Related publications
Second-Line Erlotinib in an EGFR Mutation-Negative Patient With Non-Small-Cell Lung Cancer
Current Oncology
Oncology
Erlotinib Resistance With EGFR L858r/Y891d Double Mutation in a Patient With Non–Small Cell Lung Cancer
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Radiation Pneumonitis in Patients With Non–Small-Cell Lung Cancer Treated With Erlotinib Concurrent With Thoracic Radiotherapy
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Predictive Factors Associated With Prolonged Survival in Patients With Advanced Non-Small-Cell Lung Cancer (NSCLC) Treated With Gefitinib
British Journal of Cancer
Cancer Research
Oncology
Clinical Characteristics of Osimertinib Responder in Non-Small Cell Lung Cancer Patients With EGFR-T790M Mutation
Cancers
Cancer Research
Oncology
Randomized Phase II Trial of Seribantumab in Combination With Erlotinib in Patients With EGFR Wild‐Type Non‐Small Cell Lung Cancer
Oncologist
Cancer Research
Medicine
Oncology
P2.01-90 PD-L1 Expression as a Predictive Biomarker in Advanced Non-Small Cell Lung Cancer Patients With or Without EGFR Mutation
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
P1.01-111 EGFR Exon20 Insertion Patients Treated With First-Line Chemotherapy in Non-Small Cell Lung Cancer
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Modeling Tumor Dynamics and Overall Survival in Advanced Non–Small-Cell Lung Cancer Treated With Erlotinib
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary